Please enable JavaScript to continue using this application.

Compare $ALEC vs $EVMN | Chartloom

Compare

$ALEC vs $EVMN

Alector Inc · Evommune Inc

ALEC

Alector Inc

EVMN

Evommune Inc

Compare $ALEC vs $EVMN

Comparing Alector Inc and Evommune Inc

ALECAlector Inc

EVMNEvommune Inc

ALECAlector Inc

Market cap

$231M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.29x

Rev growth (TTM)

-82.9%

YTD performance

35.9%

52W performance

-32.5%

FCF yield

-68.6%

EVMNEvommune Inc

Market cap

$225M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.9%

52W performance

-69.1%

FCF yield

-55.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALEC

EVMN

Detailed metrics comparison

ALEC

Alector Inc

EVMN

Evommune Inc

Market Cap

ALEC$231M

EVMN$225M

Enterprise Value

ALEC$181M

EVMN$166M

Price

ALEC$2.08

EVMN$6.25

P/E Ratio

ALECN/A

EVMNN/A

P/S Ratio

ALEC16.66x

EVMN14.07x

EV/Sales

ALEC13.05x

EVMN10.38x

EV/EBITDA

ALEC3.60x

EVMN0.00x

P/B Ratio

ALEC19.47x

EVMN0.90x

P/FCF Ratio

ALECN/A

EVMNN/A

EV/FCF

ALEC-1.14x

EVMN-1.33x

PEG Ratio

ALECN/A

EVMNN/A

Forward P/E (NTM)

ALECN/A

EVMNN/A

Forward P/S (NTM)

ALEC34.29x

EVMNN/A

Revenue (TTM)

ALEC$14M

EVMN$16M

Revenue Growth (YoY)

ALEC-82.9%

EVMNN/A

Forward Rev Growth

ALEC281.0%

EVMN881.5%

Gross Margin (TTM)

ALEC0.0%

EVMN0.0%

Operating Margin (TTM)

ALEC0.0%

EVMN0.0%

EBITDA Margin (TTM)

ALEC-879.7%

EVMN-1097.9%

Net Margin (TTM)

ALEC-850.1%

EVMN-943.2%

FCF Margin (TTM)

ALEC-1142.6%

EVMN-779.8%

Net Income (TTM)

ALEC$-118M

EVMN$-151M

FCF (TTM)

ALEC$-158M

EVMN$-125M

EPS (TTM)

ALEC-$1.06

EVMN-$4.18

ROE (TTM)

ALEC-29517.0%

EVMN-4676.0%

ROA (TTM)

ALEC-4400.0%

EVMN-4337.0%

ROIC (TTM)

ALEC-24053.0%

EVMN-4661.0%

Cash

ALEC$60M

EVMN$60M

Debt

ALEC$10M

EVMN$952K

Net Cash/Debt

ALEC$50M

EVMN$59M

Current Ratio (TTM)

ALEC5.26x

EVMN11.68x

Quick Ratio (TTM)

ALEC5.05x

EVMN11.48x

Debt/Equity (TTM)

ALEC0.94x

EVMN0.00x

Debt/Assets (TTM)

ALEC0.0%

EVMN0.0%

Interest Coverage (TTM)

ALECN/A

EVMNN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

EVMN0.00x

Beta

ALEC0.65

EVMN0.62

52W Performance

ALEC-32.5%

EVMN-69.1%

YTD Performance

ALEC35.9%

EVMN-63.9%

% from 52W High

ALEC-38.8%

EVMN-81.2%

% from 52W Low

ALEC90.8%

EVMN3.8%

Asset Turnover (TTM)

ALEC0.05x

EVMN0.00x

FCF Yield (TTM)

ALEC-68.6%

EVMN-55.4%

Earnings Yield (TTM)

ALEC-51.0%

EVMN-67.0%

Dividend Yield (TTM)

ALECN/A

EVMNN/A

Rule of 40

ALEC-1,225.5

EVMN-779.8

EV/GP/RG

ALECN/A

EVMNN/A

Ticker research

View ALEC research View EVMN research

Metric	ALEC Alector Inc	EVMN Evommune Inc
Market & Valuation
Market Cap	$231M	$225M
Enterprise Value	$181M	$166M
Price	$2.08	$6.25
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	14.07x
EV/Sales	13.05x	10.38x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$16M
Revenue Growth (YoY)	-82.9%	N/A
Forward Rev Growth	281.0%	881.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	-1097.9%
Net Margin (TTM)	-850.1%	-943.2%
FCF Margin (TTM)	-1142.6%	-779.8%
Net Income (TTM)	$-118M	$-151M
FCF (TTM)	$-158M	$-125M
EPS (TTM)	-$1.06	-$4.18
ROE (TTM)	-29517.0%	-4676.0%
ROA (TTM)	-4400.0%	-4337.0%
ROIC (TTM)	-24053.0%	-4661.0%
Financial Health
Cash	$60M	$60M
Debt	$10M	$952K
Net Cash/Debt	$50M	$59M
Current Ratio (TTM)	5.26x	11.68x
Quick Ratio (TTM)	5.05x	11.48x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	0.62
52W Performance	-32.5%	-69.1%
YTD Performance	35.9%	-63.9%
% from 52W High	-38.8%	-81.2%
% from 52W Low	90.8%	3.8%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-68.6%	-55.4%
Earnings Yield (TTM)	-51.0%	-67.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	-779.8
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View EVMN research

Valuation

P/S Ratio

EVMN

14.07x

ALEC

16.66x

EV/FCF

EVMN

-1.33x

ALEC

-1.14x

Growth & revenue

Revenue Growth TTM

ALEC

-82.9%

Forward Revenue Growth

EVMN

881.5%

ALEC

281.0%

Profitability & performance

Gross Margin

ALEC

0.0%

EVMN

0.0%

ROE

EVMN

-4676.0%

ALEC

-29517.0%

FCF Yield %

EVMN

-55.4%

ALEC

-68.6%

52-Week Performance

ALEC

-32.5%

EVMN

-69.1%

Detailed metrics comparison

ALEC

Alector Inc

EVMN

Evommune Inc

Market Cap

ALEC$231M

EVMN$225M

Enterprise Value

ALEC$181M

EVMN$166M

Price

ALEC$2.08

EVMN$6.25

P/E Ratio

ALECN/A

EVMNN/A

P/S Ratio

ALEC16.66x

EVMN14.07x

EV/Sales

ALEC13.05x

EVMN10.38x

EV/EBITDA

ALEC3.60x

EVMN0.00x

P/B Ratio

ALEC19.47x

EVMN0.90x

P/FCF Ratio

ALECN/A

EVMNN/A

EV/FCF

ALEC-1.14x

EVMN-1.33x

PEG Ratio

ALECN/A

EVMNN/A

Forward P/E (NTM)

ALECN/A

EVMNN/A

Forward P/S (NTM)

ALEC34.29x

EVMNN/A

Revenue (TTM)

ALEC$14M

EVMN$16M

Revenue Growth (YoY)

ALEC-82.9%

EVMNN/A

Forward Rev Growth

ALEC281.0%

EVMN881.5%

Gross Margin (TTM)

ALEC0.0%

EVMN0.0%

Operating Margin (TTM)

ALEC0.0%

EVMN0.0%

EBITDA Margin (TTM)

ALEC-879.7%

EVMN-1097.9%

Net Margin (TTM)

ALEC-850.1%

EVMN-943.2%

FCF Margin (TTM)

ALEC-1142.6%

EVMN-779.8%

Net Income (TTM)

ALEC$-118M

EVMN$-151M

FCF (TTM)

ALEC$-158M

EVMN$-125M

EPS (TTM)

ALEC-$1.06

EVMN-$4.18

ROE (TTM)

ALEC-29517.0%

EVMN-4676.0%

ROA (TTM)

ALEC-4400.0%

EVMN-4337.0%

ROIC (TTM)

ALEC-24053.0%

EVMN-4661.0%

Cash

ALEC$60M

EVMN$60M

Debt

ALEC$10M

EVMN$952K

Net Cash/Debt

ALEC$50M

EVMN$59M

Current Ratio (TTM)

ALEC5.26x

EVMN11.68x

Quick Ratio (TTM)

ALEC5.05x

EVMN11.48x

Debt/Equity (TTM)

ALEC0.94x

EVMN0.00x

Debt/Assets (TTM)

ALEC0.0%

EVMN0.0%

Interest Coverage (TTM)

ALECN/A

EVMNN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

EVMN0.00x

Beta

ALEC0.65

EVMN0.62

52W Performance

ALEC-32.5%

EVMN-69.1%

YTD Performance

ALEC35.9%

EVMN-63.9%

% from 52W High

ALEC-38.8%

EVMN-81.2%

% from 52W Low

ALEC90.8%

EVMN3.8%

Asset Turnover (TTM)

ALEC0.05x

EVMN0.00x

FCF Yield (TTM)

ALEC-68.6%

EVMN-55.4%

Earnings Yield (TTM)

ALEC-51.0%

EVMN-67.0%

Dividend Yield (TTM)

ALECN/A

EVMNN/A

Rule of 40

ALEC-1,225.5

EVMN-779.8

EV/GP/RG

ALECN/A

EVMNN/A

Ticker research

View ALEC research View EVMN research

Metric	ALEC Alector Inc	EVMN Evommune Inc
Market & Valuation
Market Cap	$231M	$225M
Enterprise Value	$181M	$166M
Price	$2.08	$6.25
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	14.07x
EV/Sales	13.05x	10.38x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$16M
Revenue Growth (YoY)	-82.9%	N/A
Forward Rev Growth	281.0%	881.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	-1097.9%
Net Margin (TTM)	-850.1%	-943.2%
FCF Margin (TTM)	-1142.6%	-779.8%
Net Income (TTM)	$-118M	$-151M
FCF (TTM)	$-158M	$-125M
EPS (TTM)	-$1.06	-$4.18
ROE (TTM)	-29517.0%	-4676.0%
ROA (TTM)	-4400.0%	-4337.0%
ROIC (TTM)	-24053.0%	-4661.0%
Financial Health
Cash	$60M	$60M
Debt	$10M	$952K
Net Cash/Debt	$50M	$59M
Current Ratio (TTM)	5.26x	11.68x
Quick Ratio (TTM)	5.05x	11.48x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	0.62
52W Performance	-32.5%	-69.1%
YTD Performance	35.9%	-63.9%
% from 52W High	-38.8%	-81.2%
% from 52W Low	90.8%	3.8%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-68.6%	-55.4%
Earnings Yield (TTM)	-51.0%	-67.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	-779.8
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View EVMN research